vs

Side-by-side financial comparison of AVINO SILVER & GOLD MINES LTD (ASM) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $21.0M, roughly 1.5× AVINO SILVER & GOLD MINES LTD). AVINO SILVER & GOLD MINES LTD runs the higher net margin — 36.6% vs 15.6%, a 21.0% gap on every dollar of revenue. On growth, AVINO SILVER & GOLD MINES LTD posted the faster year-over-year revenue change (44.0% vs -0.2%). Over the past eight quarters, AVINO SILVER & GOLD MINES LTD's revenue compounded faster (51.1% CAGR vs 28.0%).

Avino Silver & Gold Mines Ltd is a Canada-based mining company engaged in the exploration, development, and production of precious and base metals, primarily silver, gold, and copper. It operates its flagship Avino Mine property in Durango, Mexico, with its metal products supplied to global industrial and commodity markets.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

ASM vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.5× larger
OPRX
$32.2M
$21.0M
ASM
Growing faster (revenue YoY)
ASM
ASM
+44.2% gap
ASM
44.0%
-0.2%
OPRX
Higher net margin
ASM
ASM
21.0% more per $
ASM
36.6%
15.6%
OPRX
Faster 2-yr revenue CAGR
ASM
ASM
Annualised
ASM
51.1%
28.0%
OPRX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASM
ASM
OPRX
OPRX
Revenue
$21.0M
$32.2M
Net Profit
$7.7M
$5.0M
Gross Margin
47.1%
74.8%
Operating Margin
26.6%
Net Margin
36.6%
15.6%
Revenue YoY
44.0%
-0.2%
Net Profit YoY
558.9%
6535.9%
EPS (diluted)
$0.05
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASM
ASM
OPRX
OPRX
Q4 25
$32.2M
Q3 25
$21.0M
$26.1M
Q2 25
$21.8M
$29.2M
Q1 25
$18.8M
$21.9M
Q4 24
$32.3M
Q3 24
$14.6M
$21.3M
Q2 24
$14.8M
$18.8M
Q1 24
$12.4M
$19.7M
Net Profit
ASM
ASM
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$7.7M
$779.0K
Q2 25
$2.9M
$1.5M
Q1 25
$5.6M
$-2.2M
Q4 24
$-78.0K
Q3 24
$1.2M
$-9.1M
Q2 24
$1.2M
$-4.0M
Q1 24
$599.0K
$-6.9M
Gross Margin
ASM
ASM
OPRX
OPRX
Q4 25
74.8%
Q3 25
47.1%
67.2%
Q2 25
46.9%
63.8%
Q1 25
56.1%
60.9%
Q4 24
68.1%
Q3 24
39.1%
63.1%
Q2 24
31.8%
62.2%
Q1 24
18.9%
62.0%
Operating Margin
ASM
ASM
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
ASM
ASM
OPRX
OPRX
Q4 25
15.6%
Q3 25
36.6%
3.0%
Q2 25
13.1%
5.2%
Q1 25
29.8%
-10.0%
Q4 24
-0.2%
Q3 24
8.0%
-42.8%
Q2 24
8.4%
-21.3%
Q1 24
4.8%
-35.0%
EPS (diluted)
ASM
ASM
OPRX
OPRX
Q4 25
$0.27
Q3 25
$0.05
$0.04
Q2 25
$0.02
$0.08
Q1 25
$0.04
$-0.12
Q4 24
$0.00
Q3 24
$0.01
$-0.50
Q2 24
$0.01
$-0.22
Q1 24
$0.00
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASM
ASM
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$57.3M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$182.1M
$128.3M
Total Assets
$221.9M
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASM
ASM
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$57.3M
$19.5M
Q2 25
$37.3M
$16.6M
Q1 25
$26.6M
$16.6M
Q4 24
$13.4M
Q3 24
$7.8M
$16.1M
Q2 24
$5.3M
Q1 24
$3.5M
Total Debt
ASM
ASM
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
ASM
ASM
OPRX
OPRX
Q4 25
$128.3M
Q3 25
$182.1M
$122.3M
Q2 25
$144.8M
$119.3M
Q1 25
$132.3M
$116.3M
Q4 24
$117.0M
Q3 24
$114.5M
$114.5M
Q2 24
$112.2M
$121.0M
Q1 24
$107.8M
$122.5M
Total Assets
ASM
ASM
OPRX
OPRX
Q4 25
$176.9M
Q3 25
$221.9M
$170.3M
Q2 25
$174.7M
$169.3M
Q1 25
$157.7M
$167.8M
Q4 24
$171.2M
Q3 24
$135.4M
$165.2M
Q2 24
$133.7M
$172.9M
Q1 24
$128.6M
$176.4M
Debt / Equity
ASM
ASM
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASM
ASM
OPRX
OPRX
Operating Cash FlowLast quarter
$8.3M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.08×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASM
ASM
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$8.3M
$3.2M
Q2 25
$8.3M
$4.6M
Q1 25
$758.0K
$3.9M
Q4 24
$198.0K
Q3 24
$4.1M
$1.8M
Q2 24
$1.1M
$782.0K
Q1 24
$2.3M
$2.1M
Free Cash Flow
ASM
ASM
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
ASM
ASM
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
ASM
ASM
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
ASM
ASM
OPRX
OPRX
Q4 25
1.41×
Q3 25
1.08×
4.11×
Q2 25
2.92×
2.98×
Q1 25
0.13×
Q4 24
Q3 24
3.55×
Q2 24
0.87×
Q1 24
3.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons